You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
observed rates of prostate cancer incidence are dramatically impacted by uptake of PSA screening. Rapid increase in PCa diagnoses were seen in early 90s with introduction of the test, followed by a steady decrease after a large pool of previously undiagnosed cancers were detected.
the above is true for all PCa cancers, but I bet if you stratify by stage/grade, you'll see a drop in the detection of high stage/grade cancers (and an increase in low risk cancers) since the early 90's
those trends are very likely to be different for black vs white men, since black men are approx 1.5 times more likely to be diagnosed and >2 times as likely to die from PCa. Overlaid on that observed disparity is the fact that access to care (and hence, PSA screening) for these two groups has been different over time.
Interestingly, Florida has a unique population distribution in a spatial sense. Though the above statement is true for racial disparities overall, you may not see the same thing in certain rural counties. For example, Polk county has poor health outcomes by several metrics without a substantial minority population.
No description provided.
The text was updated successfully, but these errors were encountered: